Advertisement
Advances in Clinical Radiology

Current Concepts and Future Directions in Pancreatic Adenocarcinoma Staging

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Clinical Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Cancer Society
        Cancer facts & figures 2021.
        (Available at:) (Accessed January 27, 2022)
        • Rahib L.
        • Wehner M.R.
        • Matrisian L.M.
        • et al.
        Estimated projection of US cancer incidence and death to 2040.
        JAMA Netw Open. 2021; 4: e214708
        • Martin 2nd, R.C.
        • Scoggins C.R.
        • Egnatashvili V.
        • et al.
        Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
        Arch Surg. 2009; 144: 154-159
        • National Comprehensive Cancer Network
        NCCN clinical practice guidelines in oncology (NCCN guidelines®). pancreas adenocarcinoma version 2. 2021 – february 25, 2021.
        (Available at:) (Accessed March 7, 2021)
        • Ryan D.P.
        • Hong T.S.
        • Bardeesy N.
        Pancreatic adenocarcinoma.
        N Engl J Med. 2014; 371: 1039-1049
        • Lu D.S.
        • Vedantham S.
        • Krasny R.M.
        • et al.
        Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures.
        Radiology. 1996; 199: 697-701
        • Toshima F.
        • Watanabe R.
        • Inoue D.
        • et al.
        CT abnormalities of the pancreas associated with the subsequent diagnosis of clinical stage i pancreatic ductal adenocarcinoma more than 1 year later: a case-control study.
        AJR Am J Roentgenol. 2021; 217: 1353-1364
        • Javadi S.
        • Menias C.O.
        • Korivi B.R.
        • et al.
        Pancreatic calcifications and calcified pancreatic masses: pattern recognition approach on CT.
        AJR Am J Roentgenol. 2017; 209: 77-87
        • Chang S.T.
        • Jeffrey R.B.
        • Patel B.N.
        • et al.
        Preoperative multidetector CT diagnosis of extrapancreatic perineural or duodenal invasion is associated with reduced postoperative survival after pancreaticoduodenectomy for pancreatic adenocarcinoma: preliminary experience and implications for patient care.
        Radiology. 2016; 281: 816-825
        • Force U.S.P.S.T.
        • Owens D.K.
        • Davidson K.W.
        • et al.
        Screening for pancreatic cancer: us preventive services task force reaffirmation recommendation statement.
        JAMA. 2019; 322: 438-444
        • Canto M.I.
        • Almario J.A.
        • Schulick R.D.
        • et al.
        Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance.
        Gastroenterology. 2018; 155 (e742): 740-751
        • Overbeek K.A.
        • Levink I.J.M.
        • Koopmann B.D.M.
        • et al.
        Long-term yield of pancreatic cancer surveillance in high-risk individuals.
        Gut. 2021; 0: 1-9
        • Vasen H.
        • Ibrahim I.
        • Ponce C.G.
        • et al.
        Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three european expert centers.
        J Clin Oncol. 2016; 34: 2010-2019
        • Goggins M.
        • Overbeek K.A.
        • Brand R.
        • et al.
        Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the international cancer of the pancreas screening (CAPS) consortium.
        Gut. 2020; 69: 7-17
        • Syngal S.
        • Brand R.E.
        • Church J.M.
        • et al.
        ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes.
        Am J Gastroenterol. 2015; 110 (; quiz 263): 223-262
        • Daly M.B.
        • Pal T.
        • Berry M.P.
        • et al.
        Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology.
        J Natl Compr Canc Netw. 2021; 19: 77-102
        • Sharma A.
        • Kandlakunta H.
        • Nagpal S.J.S.
        • et al.
        Model to determine risk of pancreatic cancer in patients with new-onset diabetes.
        Gastroenterology. 2018; 155 (e733): 730-739
        • Moris M.
        • Bridges M.D.
        • Pooley R.A.
        • et al.
        Association between advances in high-resolution cross-section imaging technologies and increase in prevalence of pancreatic cysts from 2005 to 2014.
        Clin Gastroenterol Hepatol. 2016; 14: 585-593 e583
        • Megibow A.J.
        • Baker M.E.
        • Morgan D.E.
        • et al.
        Management of incidental pancreatic cysts: a white paper of the ACR incidental findings committee.
        J Am Coll Radiol. 2017; 14: 911-923
        • Tanaka M.
        • Fernandez-Del Castillo C.
        • Kamisawa T.
        • et al.
        Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.
        Pancreatology. 2017; 17: 738-753
        • Fung C.I.
        • Bigam D.L.
        • Wong C.K.W.
        • et al.
        Recommendations for the management of incidental pancreatic findings in adults by the canadian association of radiologists incidental findings working group.
        Can Assoc Radiol J. 2021; 73: 312-319
        • Miller F.H.
        • Lopes Vendrami C.
        • Recht H.S.
        • et al.
        Pancreatic cystic lesions and malignancy: assessment, guidelines, and the field defect.
        Radiographics. 2022; 42: 87-105
        • Freeny P.C.
        • Saunders M.D.
        Moving beyond morphology: new insights into the characterization and management of cystic pancreatic lesions.
        Radiology. 2014; 272: 345-363
        • Udare A.
        • Agarwal M.
        • Alabousi M.
        • et al.
        Diagnostic accuracy of MRI for differentiation of benign and malignant pancreatic cystic lesions compared to CT and endoscopic ultrasound: systematic review and meta-analysis.
        J Magn Reson Imaging. 2021; 54: 1126-1137
        • Boland G.W.
        • O'Malley M.E.
        • Saez M.
        • et al.
        Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma.
        AJR Am J Roentgenol. 1999; 172: 605-608
        • Ichikawa T.
        • Erturk S.M.
        • Sou H.
        • et al.
        MDCT of pancreatic adenocarcinoma: optimal imaging phases and multiplanar reformatted imaging.
        AJR Am J Roentgenol. 2006; 187: 1513-1520
        • Schueller G.
        • Schima W.
        • Schueller-Weidekamm C.
        • et al.
        Multidetector CT of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast.
        Radiology. 2006; 241: 441-448
        • Marin D.
        • Nelson R.C.
        • Barnhart H.
        • et al.
        Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of a low-tube-voltage, high-tube-current CT technique--preliminary results.
        Radiology. 2010; 256: 450-459
        • Pickhardt P.J.
        • Lubner M.G.
        • Kim D.H.
        • et al.
        Abdominal CT with model-based iterative reconstruction (MBIR): initial results of a prospective trial comparing ultralow-dose with standard-dose imaging.
        AJR Am J Roentgenol. 2012; 199: 1266-1274
        • Noda Y.
        • Iritani Y.
        • Kawai N.
        • et al.
        Deep learning image reconstruction for pancreatic low-dose computed tomography: comparison with hybrid iterative reconstruction.
        Abdom Radiol (NY). 2021; 46: 4238-4244
        • Lyu P.
        • Neely B.
        • Solomon J.
        • et al.
        Effect of deep learning image reconstruction in the prediction of resectability of pancreatic cancer: diagnostic performance and reader confidence.
        Eur J Radiol. 2021; 141: 109825
        • Almeida R.R.
        • Lo G.C.
        • Patino M.
        • et al.
        Advances in pancreatic CT imaging.
        AJR Am J Roentgenol. 2018; 211: 52-66
        • Patel B.N.
        • Thomas J.V.
        • Lockhart M.E.
        • et al.
        Single-source dual-energy spectral multidetector CT of pancreatic adenocarcinoma: optimization of energy level viewing significantly increases lesion contrast.
        Clin Radiol. 2013; 68: 148-154
        • Mileto A.
        • Ananthakrishnan L.
        • Morgan D.E.
        • et al.
        Clinical implementation of dual-energy CT for gastrointestinal imaging.
        AJR Am J Roentgenol. 2021; 217: 651-663
        • Nagayama Y.
        • Tanoue S.
        • Inoue T.
        • et al.
        Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma.
        Eur Radiol. 2020; 30: 394-403
        • McNamara M.M.
        • Little M.D.
        • Alexander L.F.
        • et al.
        Multireader evaluation of lesion conspicuity in small pancreatic adenocarcinomas: complimentary value of iodine material density and low keV simulated monoenergetic images using multiphasic rapid kVp-switching dual energy CT.
        Abdom Imaging. 2015; 40: 1230-1240
        • Noda Y.
        • Tochigi T.
        • Parakh A.
        • et al.
        Low keV portal venous phase as a surrogate for pancreatic phase in a pancreatic protocol dual-energy CT: feasibility, image quality, and lesion conspicuity.
        Eur Radiol. 2021; 31: 6898-6908
        • Amer A.M.
        • Li Y.
        • Summerlin D.
        • et al.
        Pancreatic ductal adenocarcinoma: interface enhancement gradient measured on dual-energy CT images improves prognostic evaluation.
        Radiol Imaging Cancer. 2020; 2: e190074
        • Guimaraes L.S.
        • Fletcher J.G.
        • Harmsen W.S.
        • et al.
        Appropriate patient selection at abdominal dual-energy CT using 80 kV: relationship between patient size, image noise, and image quality.
        Radiology. 2010; 257: 732-742
        • Patel B.N.
        • Alexander L.
        • Allen B.
        • et al.
        Dual-energy CT workflow: multi-institutional consensus on standardization of abdominopelvic MDCT protocols.
        Abdom Radiol (NY). 2017; 42: 676-687
        • Park M.S.
        • Klotz E.
        • Kim M.J.
        • et al.
        Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy.
        Radiology. 2009; 250: 110-117
        • Aslan S.
        • Nural M.S.
        • Camlidag I.
        • et al.
        Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
        Abdom Radiol (NY). 2019; 44: 593-603
        • Alabousi M.
        • McInnes M.D.
        • Salameh J.P.
        • et al.
        MRI vs. CT for the detection of liver metastases in patients with pancreatic carcinoma: a comparative diagnostic test accuracy systematic review and meta-analysis.
        J Magn Reson Imaging. 2021; 53: 38-48
        • Qayyum A.
        • Tamm E.P.
        • Kamel I.R.
        • et al.
        • Expert Panel on Gastrointestinal Imaging
        ACR appropriateness criteria((R)) staging of pancreatic ductal adenocarcinoma.
        J Am Coll Radiol. 2017; 14: S560-S569
        • Al-Hawary M.M.
        • Francis I.R.
        • Chari S.T.
        • et al.
        Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association.
        Radiology. 2014; 270: 248-260
        • Li H.
        • Zeng M.S.
        • Zhou K.R.
        • et al.
        Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion.
        J Comput Assist Tomogr. 2005; 29: 170-175
        • Lu D.S.
        • Reber H.A.
        • Krasny R.M.
        • et al.
        Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT.
        AJR Am J Roentgenol. 1997; 168: 1439-1443
        • Tran Cao H.S.
        • Balachandran A.
        • Wang H.
        • et al.
        Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.
        J Gastrointest Surg. 2014; 18 (discussion 278): 269-278
        • Hough T.J.
        • Raptopoulos V.
        • Siewert B.
        • et al.
        Teardrop superior mesenteric vein: CT sign for unresectable carcinoma of the pancreas.
        AJR Am J Roentgenol. 1999; 173: 1509-1512
        • Joo I.
        • Lee J.M.
        • Lee E.S.
        • et al.
        Preoperative CT classification of the resectability of pancreatic cancer: interobserver agreement.
        Radiology. 2019; 293: 343-349
        • Hong S.B.
        • Lee S.S.
        • Kim J.H.
        • et al.
        Pancreatic cancer CT: prediction of resectability according to NCCN criteria.
        Radiology. 2018; 289: 710-718
        • Loch F.N.
        • Asbach P.
        • Haas M.
        • et al.
        Accuracy of various criteria for lymph node staging in ductal adenocarcinoma of the pancreatic head by computed tomography and magnetic resonance imaging.
        World J Surg Oncol. 2020; 18: 213
        • Zhang Y.
        • Huang J.
        • Chen M.
        • et al.
        Preoperative vascular evaluation with computed tomography and magnetic resonance imaging for pancreatic cancer: a meta-analysis.
        Pancreatology. 2012; 12: 227-233
        • Peixoto R.D.
        • Speers C.
        • McGahan C.E.
        • et al.
        Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.
        Cancer Med. 2015; 4: 1171-1177
        • De Rosa A.
        • Cameron I.C.
        • Gomez D.
        Indications for staging laparoscopy in pancreatic cancer.
        HPB (Oxford). 2016; 18: 13-20
        • Oba A.
        • Ho F.
        • Bao Q.R.
        • et al.
        Neoadjuvant treatment in pancreatic cancer.
        Front Oncol. 2020; 10: 245
        • Katz M.H.
        • Fleming J.B.
        • Bhosale P.
        • et al.
        Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators.
        Cancer. 2012; 118: 5749-5756
        • Ferrone C.R.
        • Marchegiani G.
        • Hong T.S.
        • et al.
        Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.
        Ann Surg. 2015; 261: 12-17
        • Zins M.
        • Matos C.
        • Cassinotto C.
        Pancreatic Adenocarcinoma staging in the era of preoperative chemotherapy and radiation therapy.
        Radiology. 2018; 287: 374-390
        • Cassinotto C.
        • Cortade J.
        • Belleannee G.
        • et al.
        An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment.
        Eur J Radiol. 2013; 82: 589-593
        • Jang J.K.
        • Byun J.H.
        • Kang J.H.
        • et al.
        CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
        Eur Radiol. 2021; 31: 813-823
        • Kim Y.E.
        • Park M.S.
        • Hong H.S.
        • et al.
        Effects of neoadjuvant combined chemotherapy and radiation therapy on the CT evaluation of resectability and staging in patients with pancreatic head cancer.
        Radiology. 2009; 250: 758-765
        • Soloff E.
        • Al-Hawary M.
        • Desser T.S.
        • et al.
        Imaging assessment of pancreatic cancer resectability after neoadjuvant therapy: AJR expert panel narrative review.
        AJR Am J Roentgenol. 2021; 218: 570-581
        • Cassinotto C.
        • Mouries A.
        • Lafourcade J.P.
        • et al.
        Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy.
        Radiology. 2014; 273: 108-116
        • Chu L.C.
        • Park S.
        • Kawamoto S.
        • et al.
        Utility of CT radiomics features in differentiation of pancreatic ductal adenocarcinoma from normal pancreatic tissue.
        AJR Am J Roentgenol. 2019; 213: 349-357
        • Kulkarni A.
        • Carrion-Martinez I.
        • Jiang N.N.
        • et al.
        Hypovascular pancreas head adenocarcinoma: CT texture analysis for assessment of resection margin status and high-risk features.
        Eur Radiol. 2020; 30: 2853-2860
        • Rigiroli F.
        • Hoye J.
        • Lerebours R.
        • et al.
        CT radiomic features of superior mesenteric artery involvement in pancreatic ductal adenocarcinoma: a pilot study.
        Radiology. 2021; 301: 610-622
        • Eilaghi A.
        • Baig S.
        • Zhang Y.
        • et al.
        CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis.
        BMC Med Imaging. 2017; 17: 38
        • Kulkarni A.
        • Carrion-Martinez I.
        • Dhindsa K.
        • et al.
        Pancreas adenocarcinoma CT texture analysis: comparison of 3D and 2D tumor segmentation techniques.
        Abdom Radiol (NY). 2021; 46: 1027-1033
        • Abunahel B.M.
        • Pontre B.
        • Kumar H.
        • et al.
        Pancreas image mining: a systematic review of radiomics.
        Eur Radiol. 2021; 31: 3447-3467
        • Liu K.L.
        • Wu T.
        • Chen P.T.
        • et al.
        Deep learning to distinguish pancreatic cancer tissue from non-cancerous pancreatic tissue: a retrospective study with cross-racial external validation.
        Lancet Digit Health. 2020; 2: e303-e313
        • Kaissis G.
        • Ziegelmayer S.
        • Lohofer F.
        • et al.
        A machine learning model for the prediction of survival and tumor subtype in pancreatic ductal adenocarcinoma from preoperative diffusion-weighted imaging.
        Eur Radiol Exp. 2019; 3: 41
        • Prokesch R.W.
        • Chow L.C.
        • Beaulieu C.F.
        • et al.
        Isoattenuating pancreatic adenocarcinoma at multi-detector row CT: secondary signs.
        Radiology. 2002; 224: 764-768
        • Yoon S.H.
        • Lee J.M.
        • Cho J.W.
        • et al.
        Small (</= 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT.
        Radiology. 2011; 259: 442-452
        • Choi T.W.
        • Km J.K.
        • Yu M.H.
        • et al.
        Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis.
        Acta Radiol. 2018; 59: 383-392
        • Kawamoto S.
        • Shi C.
        • Hruban R.H.
        • et al.
        Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction.
        AJR Am J Roentgenol. 2011; 197: W482-W488
        • Ichikawa T.
        • Sou H.
        • Araki T.
        • et al.
        Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas.
        Radiology. 2001; 221: 107-116
        • Poruk K.E.
        • Gay D.Z.
        • Brown K.
        • et al.
        The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates.
        Curr Mol Med. 2013; 13: 340-351
        • Tatli S.
        • Mortele K.J.
        • Levy A.D.
        • et al.
        CT and MRI features of pure acinar cell carcinoma of the pancreas in adults.
        AJR Am J Roentgenol. 2005; 184: 511-519
        • Merkle E.M.
        • Bender G.N.
        • Brambs H.J.
        Imaging findings in pancreatic lymphoma: differential aspects.
        AJR Am J Roentgenol. 2000; 174: 671-675
        • Prayer L.
        • Shurawitzki H.
        • Mallek R.
        • et al.
        CT in pancreatic involvement of non-Hodgkin lymphoma.
        Acta Radiol. 1992; 33: 123-127
        • Schawkat K.
        • Manning M.A.
        • Glickman J.N.
        • et al.
        Pancreatic ductal adenocarcinoma and its variants: pearls and perils.
        Radiographics. 2020; 40: 1219-1239